access & assistance for alk , ros1 & egfr patients
Published 8 years ago • 131 plays • Length 14:18Download video MP4
Download video MP3
Similar videos
-
31:43
new ideas and new treatment options for acquired resistance for alk/ros1
-
29:51
current & emerging approaches to acquired resistance for alk/ros1
-
4:08
2020 ttf alk/ros session qa panel treatment decisions for simultaneous egfr and ros1 mutation
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
1:59:57
grace - global resource for advancing cancer education live stream
-
25:07
2020 ttf alk session - lin - tkis for ros1
-
1:47
alk rearrangements: what are they, and who has them?
-
2:07
grace targeted therapies lung cancer 2021 - ros1 & alk treatments transform neuroendocrine tumor
-
28:15
panel q&a session on alk and ros1 acquired resistance with drs. horn and owonikoko
-
2:01
grace targeted therapies lung cancer 2021 - data learned from ensartinib for ros1 in clinical trial?
-
1:07:25
ros1 alk initial treatment, acquired resistance with melina marmarelis, md and charu aggarwal, md
-
26:56
gracecast-085_lung-cancer_alk inhibition: who to screen and options for alk-positive patients
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
3:06
grace targeted therapies lung cancer 2021 - tki plus chemotherapy as a firstline treatment in ros1?
-
1:58
grace targeted therapies lung cancer 2021 - other data for alk positive lung cancer?
-
4:31
grace targeted therapies lung cancer 2021 -recommended 2nd line & timing, stage 3 ros-1 lung cancer?
-
2:16
2020 ttf alk session qa panel ros1 patients on immunotherapy chemotherapy combinations
-
6:49
can we improve on xalkori? new agents for patients with an alk-1 rearrangement